Keep abreast of the latest in business. Get notified about stories and events as they happen.

Current Affairs

Mutual Fund Tools

BS Fund Manager

Financial X-Ray

Editorial Comment

Business Law & Tax

Sponsored Content

Loans & Credit Cards

Financial Tools

Pharmaceuticals

Essentials tag unlikely to benefit pharmaceutical companies in Q1

Top govt scientists tell MPs Covid-19 vaccine at least a year away

Cipla set to undercut rivals with low-priced generic remdesivir: Report

Despite poor show in Q4, India Inc's combined dividend payout rises 6.5%

DRL to launch innovator brand of favipiravir, is silent on pricing

Pharmaceuticals body seeks faster clearances of imported goods at ports

Gilead prices Covid-19 drug remdesivir at $2,340 in developed nations

Infosys launches personalised medicine solution for pharmaceutical cos

Sun Pharma to launch its first innovative product for psoriasis in Japan

The oil factor

Next